Actinium Pharmaceuticals
ATNM
ATNM
24 hedge funds and large institutions have $8.12M invested in Actinium Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
72% less call options, than puts
Call options by funds: $62K | Put options by funds: $221K
Holders
24
Holding in Top 10
–
Calls
$62K
Puts
$221K
Top Buyers
| 1 | +$586K | |
| 2 | +$378K | |
| 3 | +$352K | |
| 4 |
Bank of New York Mellon
New York
|
+$228K |
| 5 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$161K |
Top Sellers
| 1 | -$292K | |
| 2 | -$169K | |
| 3 | -$159K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$121K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$93K |